Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 25;8(12):eabp8322.
doi: 10.1126/sciadv.abp8322. Epub 2022 Mar 23.

Illuminating the lung regenerative potential of prostanoids

Sean M Fortier  1 , Loka R Penke  1 , Marc Peters-Golden  1
Affiliations
Review

Illuminating the lung regenerative potential of prostanoids

Sean M Fortier et al. Sci Adv. .

Abstract

PGE2 and PGI2 receptors are potential targets for the treatment of chronic lung disease.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.. Potential actions of prostanoids in lung regeneration.
Prostanoids PGE2 and PGI2 are synthesized by and bind to G protein–coupled receptors in lung epithelial, mesenchymal, and immune cells. The resulting increase in intracellular levels of the second messenger cAMP reprograms gene expression in lung epithelial cells, including an up-regulation of circadian clock genes, promoting lung tissue repair and homeostasis. Administration of stable prostanoid agonists targeting the PGE2 receptors EP2 and EP4 and/or the PGI2 receptor IP may promote the regeneration of damaged lung in COPD and other chronic lung diseases. Credit: Kellie Holoski/Science Advances.
See this image and copyright information in PMC

Comment in

  • doi: 10.1126/sciadv.abj9949

Similar articles

See all similar articles

Cited by

References

    1. Barnes P. J., Anderson G. P., Fagerås M., Belvisi M. G., Chronic lung diseases: Prospects for regeneration and repair. Eur. Respir. Rev. 30, 200213 (2021). - PMC - PubMed
    1. Wu X., Bos I. S. T., Conlon T. M., Ansari M., Verschut V., van der Koog L., Verkleij L. A., D’Ambrosi A., Matveyenko A., Schiller H. B., Königshoff M., Schmidt M., Kistemaker L. E. M., Yildirim A. Ö., Gosens R., A transcriptomics-guided drug target discovery strategy identifies novel receptor ligands for lung regeneration. Sci. Adv. 8, eabj9949 (2022). - PMC - PubMed
    1. Narumiya S., Sugimoto Y., Ushikubi F., Prostanoid receptors: Structures, properties, and functions. Physiol. Rev. 79, 1193–1226 (1999). - PubMed
    1. Shimizu T., Lipid mediators in health and disease: Enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 49, 123–150 (2009). - PubMed
    1. Ricciotti E., FitzGerald G. A., Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 31, 986–1000 (2011). - PMC - PubMed

LinkOut - more resources